Android app on Google Play

BMO Starts ArQule (ARQL), Pharmasset (VRUS) at Outperform

September 29, 2010 5:28 PM EDT Send to a Friend
Get Alerts ARQL Hot Sheet
Price: $1.20 +2.56%

Rating Summary:
    3 Buy, 6 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 24 | New: 21
Trade ARQL Now!
Join SI Premium – FREE
An analyst at BMO Capital has initiated coverage on several stocks in the Biotech & Drugs sector this afternoon, both with Outperform ratings: ArQule (Nasdaq: ARQL) and Pharmasset (Nasdaq: VRUS).

The firm set a $10 price target on ArQule shares and a $41 price target on shares of Pharmasset.

You May Also Be Interested In

Related Categories

New Coverage

Related Entities

BMO Capital

Add Your Comment